Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Common Stock | 519K | $872K | $1.68 | Jan 31, 2024 | Direct |
Akebia Therapeutics, Inc. | SVP, CFO and Treasurer | Stock Option (Right to buy) | 224K | Jan 31, 2024 | Direct | ||
Pear Therapeutics, Inc. | VP, Chief Accounting Officer | Restricted Stock Units | 40K | Feb 16, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. | Jan 31, 2024 | 2 | $0 | 4 | Feb 2, 2024 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Jul 31, 2023 | 2 | $0 | 4 | Aug 1, 2023 | SVP, CFO and Treasurer |
AKBA | Akebia Therapeutics, Inc. | Jul 10, 2023 | 0 | $0 | 3 | Jul 18, 2023 | SVP, CFO and Treasurer |
PEARQ | Pear Therapeutics, Inc. | Feb 15, 2023 | 2 | $0 | 4 | Feb 17, 2023 | VP, Chief Accounting Officer |
PEARQ | Pear Therapeutics, Inc. | Jan 20, 2023 | 1 | -$9.07K | 4 | Jan 24, 2023 | Chief Accounting Officer |
PEARQ | Pear Therapeutics, Inc. | Jan 14, 2023 | 2 | $0 | 4 | Jan 18, 2023 | Chief Accounting Officer |
PEARQ | Pear Therapeutics, Inc. | Feb 16, 2022 | 1 | $0 | 4 | Feb 18, 2022 | Chief Accounting Officer |
PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 1 | $0 | 4 | Dec 7, 2021 | Chief Accounting Officer |
PEARQ | Pear Therapeutics, Inc. | Dec 3, 2021 | 0 | $0 | 3 | Dec 7, 2021 | Chief Accounting Officer |